therapeutic 4,093 words KG: neuroprotection
Contents

Neuroprotection Strategies in Neurodegeneration

💊 Therapeutic Info
Nameneuroprotection
Key Genes/ProteinsAkt, AKT, ALOX15, AMPK, APOE, APOE2
Related DiseasesAlzheimer's Disease
Related Pathwaysamyloid clearance, astrocyte-specific complement inhibition

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (167)

R-Loop Resolution Enhancement Therapy
Score: 0.68
Chaperone-Mediated APOE4 Refolding Enhancement
Score: 0.68
Osmotic Gradient Restoration via Selective AQP1 Enhancement
Score: 0.68
Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution
Score: 0.68
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.67
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
Partial Neuronal Reprogramming via Modified Yamanaka Cocktai
Score: 0.67
Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
Lipid Droplet Dynamics as Phenotype Switches
Score: 0.67
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.67
Complement C1q Subtype Switching
Score: 0.66
RNA Granule Nucleation Site Modulation
Score: 0.66
Biorhythmic Interference via Controlled Sleep Oscillations
Score: 0.66
Temporal TET2-Mediated Hydroxymethylation Cycling
Score: 0.66
Mitochondrial RNA Granule Rescue Pathway
Score: 0.66
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66
Arginine Methylation Enhancement Therapy
Score: 0.65
KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.65
Microbial Inflammasome Priming Prevention
Score: 0.65
← Prevpg 5/9Next →

Related Analyses (30)

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Extracellular vesicle biomarkers for early AD detection
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived
Cell type vulnerability in Alzheimers Disease (SEA-AD transc
neurodegeneration · archived

Related Experiments (30)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40
Selective Vulnerability of Dopaminergic Neurons — Mechanism
validation · proposed · Score: 0.40
Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40
DLB Treatment Response Biomarkers — Predicting Cholinesteras
clinical · proposed · Score: 0.40

See Also (15)

Swedish BioFINDER 2 Study: Biomarkers and Neurodegenera
clinical · Pages share 135 hypotheses
China Neurodegeneration Epidemiology
disease · Pages share 135 hypotheses
Neuroimaging for Parkinsonian Syndromes (NCT03872102)
clinical · Pages share 26 hypotheses
Synaptic Biomarkers in Neurodegeneration
biomarker · Pages share 135 hypotheses
BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 135 hypotheses

Knowledge Graph (12 edges)

vagal_signaling_pathway activates neuroprotection
PI3K/Akt/mTOR activates neuroprotection
microglial efferocytosis activates neuroprotection
BECN1 activates neuroprotection
autophagy activates neuroprotection
plant-derived secondary metabolites activates neuroprotection
integrated stress response activates neuroprotection
AKT associated_with neuroprotection
PI3K/AKT enhances neuroprotection
microglial APOE4 deletion promotes neuroprotection

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.